Big Pharma Exec Suddenly Collapses in the Oval Office During Drug Pricing Event [WATCH]

A pharmaceutical executive standing behind President Donald Trump during a White House event on Thursday collapsed unexpectedly, prompting officials to stop the live broadcast as medical personnel rushed to assist.

The incident occurred in the Oval Office during President Trump’s announcement on obesity drug pricing initiatives, which included remarks from pharmaceutical executives and medical professionals.

“Are you OK? Gordon, you OK?” asked Eli Lilly CEO David Ricks as the man began to lose consciousness.

“Press out!” officials shouted as President Trump immediately stood from his seat at the Resolute Desk. Dr. Mehmet Oz, who was among those in attendance, quickly stepped forward to help.

The man who collapsed was identified by multiple news outlets as Gordon Findlay, an executive at Novo Nordisk, the pharmaceutical company that manufactures the widely known obesity and diabetes medications Ozempic, Rybelsus, and Wegovy.

White House officials confirmed that Findlay was treated on site and later reported to be in stable condition. The cause of the medical episode has not been made public.

This Could Be the Most Important Video Gun Owners Watch All Year

White House Press Secretary Karoline Leavitt released a statement following the incident. “During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted,” Leavitt said.

“The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”

The event, part of President Trump’s continuing efforts to address obesity treatment costs and accessibility, featured remarks from leaders of major pharmaceutical companies and healthcare organizations.

The administration has been working with industry representatives to expand affordability options for new obesity treatments that have gained popularity nationwide.

Following the incident, White House staff and security personnel cleared members of the press from the room as medical personnel attended to Findlay.

Reporters were later told the press conference would continue once the situation stabilized.

White House Press Secretary Karoline Leavitt confirms that Novo Nordisk executive Gordon Findlay, who fainted during President Trump’s weight-loss drug pricing announcement, is “OK”. pic.twitter.com/ukr4gDR9QB

— MAGA Kitty (@SaveUSAKitty) November 6, 2025

Observers noted that the collapse occurred shortly after the formal portion of the announcement began.

Video of the incident briefly circulated before the feed was cut, showing President Trump reacting quickly as aides called for assistance.

The White House later confirmed that the remainder of the event proceeded after a short delay, and that all participants were safe.

Novo Nordisk, headquartered in Denmark, has not released a public statement regarding Findlay’s condition but confirmed through a company spokesperson that one of its executives experienced a “medical situation” during the event and received immediate medical attention.

Fainting or medical episodes during public events are not uncommon, particularly under the intense lighting and long standing periods associated with televised White House ceremonies.

President Trump, who resumed the announcement after the pause, continued outlining new measures intended to promote competitive pricing in the pharmaceutical industry and reduce costs for patients using obesity and diabetes medications.

The White House Medical Unit remained on site for the duration of the event as a precaution. Officials did not provide further details about Findlay’s condition but reiterated that he was “okay” and expected to recover fully.